Eli Lilly (LLY) Shares Outstanding (2009 - 2026)

Eli Lilly (LLY) has 18 years of Shares Outstanding data on file, last reported at $943.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding changed 0.49% year-over-year to $943.5 million; the trailing twelve-month figure through Mar 2026 stood at $943.5 million (changed 0.49% YoY), and the FY2025 full-year result was $944.8 million, changed 0.33% from the prior year.
• Shares Outstanding for Q1 2026 stood at $943.5 million, roughly flat from $944.8 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $950.8 million in Q2 2024 and bottomed at $943.5 million in Q1 2026.
• The 5-year median for Shares Outstanding is $949.7 million (2023), against an average of $948.9 million.
• The widest annual swing landed in 2022, when Shares Outstanding declined 0.93%; it then increased 0.12% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $950.6 million in 2022, then slipped by 0.08% to $949.8 million in 2023, then slipped by 0.2% to $947.9 million in 2024, then retreated by 0.33% to $944.8 million in 2025, then declined by 0.14% to $943.5 million in 2026.
• The last three Shares Outstanding figures came in at $943.5 million (Q1 2026), $944.8 million (Q4 2025), and $946.2 million (Q3 2025), per Business Quant data.

Peer Comparison